Leica Biosystems Nussloch Competitors and Similar CompaniesClear all

Leica Biosystems Nussloch's competitors and similar companies include Preora Healthcare, GratXray, Spectros Medical Devices and Roche.

	Leica Biosystems Nussloch Leica Biosystems Nussloch is a medical device company that develops cancer diagnostic products.	Preora Healthcare Preora Healthcare (formerly Preora Diagnostics) is a medical device company developing technology for the early detection and treatment of cancer.	GratXray GratXray is a medical device company that develops and markets systems based on phase contrast-enhanced X-ray imaging.	Spectros Medical Devices Spectros Medical Devices is a company that develops molecular sensing devices and software products.	Roche Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.
Founding Date	Founding Date 1989	Founding Date 2015	Founding Date 2017	Founding Date 2019	Founding Date 1896
Type	Type Subsidiary	Type Private	Type Private	Type Private	Type Public
Tags	Tags Manufacturing & Industrial medical devices medical diagnostics oncology	Tags Healthcare medical devices medical diagnostics medtech oncology	Tags Healthcare medical devices medical diagnostics medical imaging oncology women's health	Tags Technology application software healthtech medical devices	Tags Healthcare biotech drug development medical diagnostics pharma
Locations	Locations Nußloch, DE HQ Mumbai, IN Buffalo Grove, US Deer Park, US	Locations Evanston, US HQ	Locations Villigen, CH HQ	Locations Houston, US HQ	Locations Basel, CH HQ Hydra, DZ Ricardo Rojas, AR North Ryde, AU Sydney, AU Wien, AT Dhaka, BD see more
Employees	Employees 38918% increase	Employees 1	Employees 5	Employees 3	Employees 103,249
Financial
Revenue (est.)	Revenue (est.) $254.8m (FY, 2022)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) CHF61.5b (FY, 2025)
Cost of goods	Cost of goods $154.7m (FY, 2022)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods CHF13.1b (FY, 2025)
Gross profit	Gross profit $100.1m (FY, 2022)	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit CHF50.5b (FY, 2025)
Net income	Net income $32.6m (FY, 2022)	Net income N/A	Net income N/A	Net income N/A	Net income CHF13.8b (FY, 2025)